Rutgers University showcased two of its best startup inventions at University Startup Demo Day, in Washington, D.C., earlier this week. Two new companies, Celvive Inc., and XPEED Turbine Technology, LLC, (XTT) presented in front of Congress members and staff, as well as venture capitalists, angel investors, and corporate representatives.
Rutgers senior vice president, Christopher J. Molloy, for research and economic development, spoke to the companies’ strength in life science and technology.
“Professors Diez and Sabaawy exemplify the many brilliant and inventive faculty researchers at Rutgers, and I congratulate them for this recognition,” Molloy said. “Rutgers innovation has led to more than 50 currently active startup companies, and we are working hard to support our faculty’s research and their technology commercialization efforts.”
Celvive Inc. is refining a technology that its founders have developed for the isolation and use of stem cells for regenerative medicine applications, including helping neural regeneration in patients with spinal cord injury. The Rutgers-patented technology uses a device with multiple closed-bag systems to isolate specific adult stem cells from the patient’s own bone marrow.
XPEED Turbine Technology, LLC (XTT), is developing aerodynamic flow deflector technology that will reduce the cost of wind energy by improving wind turbine efficiency and increasing annual energy production. The new technology can be applied to any currently operating turbine, does not require any external power to function and can be combined with vortex generators.